Eisai Files Application For Additional Indication Of Aricept For Lewy Body Dementia In Japan
This article was originally published in PharmAsia News
Executive Summary
Eisai filed an application in Japan for an additional indication of Lewy Body Dementia for Alzheimer’s drug Aricept (donepezil).